{"id":117317,"date":"2026-08-31T16:55:44","date_gmt":"2026-08-31T13:55:44","guid":{"rendered":"https:\/\/prizrenpost.com\/al\/zbulohet-trajtimi-qe-ul-kolesterolin-e-keq-me-rreth-50-per-nje-vit\/"},"modified":"2026-08-31T16:55:44","modified_gmt":"2026-08-31T13:55:44","slug":"zbulohet-trajtimi-qe-ul-kolesterolin-e-keq-me-rreth-50-per-nje-vit","status":"publish","type":"post","link":"https:\/\/prizrenpost.com\/al\/zbulohet-trajtimi-qe-ul-kolesterolin-e-keq-me-rreth-50-per-nje-vit\/","title":{"rendered":"Zbulohet trajtimi q\u00eb ul kolesterolin e keq me rreth 50% p\u00ebr nj\u00eb vit"},"content":{"rendered":"<figure class=\"post-featured-image\"><img decoding=\"async\" src=\"https:\/\/prizrenpost.com\/al\/wp-content\/uploads\/2026\/08\/dddd1788078792.jpg\" alt=\"Zbulohet trajtimi q\u00eb ul kolesterolin e keq me rreth 50% p\u00ebr nj\u00eb vit\"\/><\/figure>\n<p>Nj\u00eb terapi eksperimentale me teknologjin\u00eb CRISPR-Cas9 ka ulur ndjesh\u00ebm kolesterolin LDL dhe trigliceridet, edhe nj\u00eb vit pas nj\u00eb doze t\u00eb vetme. Studiuesit e konsiderojn\u00eb rezultatin premtues, por paralajm\u00ebrojn\u00eb se nevojiten prova m\u00eb t\u00eb m\u00ebdha.<\/p>\n<p>Nj\u00eb trajtim i ri gjenetik mund t\u00eb hap\u00eb nj\u00eb rrug\u00eb t\u00eb re p\u00ebr pacient\u00ebt me kolesterol shum\u00eb t\u00eb lart\u00eb dhe t\u00eb v\u00ebshtir\u00eb p\u00ebr t\u2019u kontrolluar.<\/p>\n<p>Terapia eksperimentale CTX310 synon gjenin ANGPTL3 n\u00eb m\u00ebl\u00e7i, i cili lidhet me rregullimin e kolesterolit dhe triglicerideve. N\u00eb studimin e faz\u00ebs s\u00eb par\u00eb, me vet\u00ebm 15 pacient\u00eb, doza m\u00eb e lart\u00eb e trajtimit uli LDL-n\u00eb me rreth 53% edhe pas nj\u00eb viti, nd\u00ebrsa trigliceridet u ul\u00ebn me afro 48%.<\/p>\n<p>Rezultati \u00ebsht\u00eb ve\u00e7an\u00ebrisht interesant sepse b\u00ebhet fjal\u00eb p\u00ebr nj\u00eb doz\u00eb t\u00eb vetme, n\u00eb vend t\u00eb trajtimeve q\u00eb duhet t\u00eb merren n\u00eb m\u00ebnyr\u00eb t\u00eb vazhdueshme.<\/p>\n<p>Megjithat\u00eb, shkenc\u00ebtar\u00ebt theksojn\u00eb se k\u00ebto jan\u00eb rezultate shum\u00eb t\u00eb hershme. CRISPR ndryshon drejtp\u00ebrdrejt ADN-n\u00eb dhe efekti mund t\u00eb jet\u00eb i pakthyesh\u00ebm, ndaj siguria afatgjat\u00eb mbetet nj\u00eb shqet\u00ebsim kryesor.<\/p>\n<p>Studimi raportoi gjithashtu nj\u00eb ulje prej rreth 20% t\u00eb HDL-s\u00eb, nd\u00ebrsa nj\u00eb pacient q\u00eb mori doz\u00ebn m\u00eb t\u00eb ul\u00ebt vdiq 179 dit\u00eb pas trajtimit; autor\u00ebt nuk e lidh\u00ebn vdekjen me terapin\u00eb.<\/p>\n<p>N\u00ebse rezultatet konfirmohen n\u00eb studime m\u00eb t\u00eb m\u00ebdha, kjo teknologji mund t\u00eb ndryshoj\u00eb m\u00ebnyr\u00ebn e trajtimit t\u00eb kolesterolit t\u00eb lart\u00eb. P\u00ebr momentin, megjithat\u00eb, CTX310 mbetet nj\u00eb terapi eksperimentale dhe nuk z\u00ebvend\u00ebson trajtimet ekzistuese.<\/p>\n<hr style=\"margin:30px 0\"\/>\n<p style=\"font-size:13px;color:#666\">Burimi: <strong>mesazhi<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nj\u00eb terapi eksperimentale me teknologjin\u00eb CRISPR-Cas9 ka ulur ndjesh\u00ebm kolesterolin LDL dhe trigliceridet, edhe nj\u00eb vit pas nj\u00eb doze t\u00eb vetme. Studiuesit e konsiderojn\u00eb rezultatin premtues, por paralajm\u00ebrojn\u00eb se nevojiten prova m\u00eb t\u00eb m\u00ebdha. Nj\u00eb trajtim i ri gjenetik mund t\u00eb hap\u00eb nj\u00eb rrug\u00eb t\u00eb re p\u00ebr pacient\u00ebt me kolesterol shum\u00eb t\u00eb lart\u00eb dhe t\u00eb [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":117316,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-117317","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-shendetesi"],"_links":{"self":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/117317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/comments?post=117317"}],"version-history":[{"count":0,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/117317\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media\/117316"}],"wp:attachment":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media?parent=117317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/categories?post=117317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/tags?post=117317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}